CLINICAL_TRIALS
trial_result
· 2014-07-21
Clinical Trial Update: Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab [Phase 1]
Summary
A Phase 1 study investigated immune responses to systemic and mucosal antigenic challenge in patients treated with vedolizumab for inflammatory bowel disease; t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Inflammatory Bowel Disease | Phase 1 | Status: COMPLETED | Results posted: 2014-07-21